Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.4800 (-0.5%) ($41.4800 - $41.4800) on Tue. Apr. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.22% (three month average) | RSI | 84 | Latest Price | $41.4800(-0.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.6% a day on average for past five trading days. | Weekly Trend | HALO advances 5.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(44%) IWM(43%) IWN(42%) IWC(40%) | Factors Impacting HALO price | HALO will decline at least -1.11% in a week (0% probabilities). VIXM(-23%) UUP(-10%) VXX(-8%) EDOC(-7%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.11% (StdDev 2.22%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.98(1.22%) | 10 Day Moving Average | $39.95(3.83%) | 20 Day Moving Average | $38.12(8.81%) | To recent high | -0.5% | To recent low | 29.8% | Market Cap | $5.669b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |